BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Amgen Breaks Through as FDA Approves Lumakras for Elusive KRAS Mutation

  The FDA gave the green light to Amgen’s Lumakras under accelerated approval as a treatment for patients with KRAS mutation whose disease has worsened over time.

  June 1, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Safety Concerns Cause Novartis to Hit the Brakes on Three Late-Stage Trials for Eye Drug Beovu

  The early termination of the Beovu trials places a damper on Novartis’ hopes of competing even further with Regeneron Pharmaceuticals’ retinal disease drug Eylea.

  June 1, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  Drug Development

  FDA Approves BridgeBio-QED Therapeutics’ Targeted Liver Cancer Treatment Truseltiq

  The FDA approves Truseltiq for patients with previously-treated locally advanced or metastatic cholangiocarcinoma with an FGFR2 fusion or rearrangement.

  June 1, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Sanofi Halts Kidney Disease Program Studying Venglustat Drug

  Sanofi said that the phase II/III trial studying venglustat in autosomal dominant polycystic kidney disease was scrapped because it “did not meet futility criteria.”

  June 1, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  BioMark Receives $825K Grant to Develop Its Liquid Biopsy Assay for Lung Cancer Screening

  The overarching goal is to develop a low-cost, high-throughput test that will make early-stage lung cancer screening feasible and affordable for at-risk population.

  June 1, 2021

   · 

  6 min read
• 

  Business

  Female-Founded and Funded Capsida Taps Swati Tole as Chief Medical Officer

  Newly entrenched in a leadership role within one of the most complex therapeutic spaces, Tole discussed the complexities of being both a woman and a woman of color in the biotech industry.

  June 1, 2021

   · 

  4 min read

   · 

  Heather McKenzie
• 

  Business

  Amgen Reunites With Kyowa Kirin in $400 Million Atopic Dermatitis Deal

  Amgen reunites with Kyowa Kirin on the development and potential commercialization of KHK4083, an atopic dermatitis drug, which impacts nearly 30 million people worldwide.

  June 1, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  COVID-19 Update: New Naming System, Support for Investigation and More

  The latest news in COVID-19 includes support for an investigation into the origins of the virus, a new naming system, and legal discussions of whether employers can mandate vaccination.

  June 1, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  MyMD Pharma Develops Low-Toxicity, Plant-Based TNF-α Regulator

  MyMD Pharmaceuticals’ TNF-α regulator may be able to be commercialized without the black-box warnings that accompany so many TNF-α therapies.

  June 1, 2021

   · 

  4 min read

   · 

  Gail Dutton
• 

  Drug Development

  HALT: AB Science Announces Worldwide Voluntary Hold on Lead Compound Masitinib

  Inclusions and treatment initiation will be paused in all ongoing clinical studies until an investigation into the potential safety issue is complete.

  June 1, 2021

   · 

  2 min read

   · 

  Heather McKenzie